Skip to main content

Advertisement

SpringerLink
Log in

Depression in People with Coronary Heart Disease: Prognostic Significance and Mechanisms

  • Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Depression affects about 40 % of people with coronary heart disease (CHD). This group with depression and CHD have increased mortality and morbidity, worse health-related quality of life, use health services more frequently and consequently cost the health service and the national economy considerably more than their non-depressed counterparts. A number of characteristics of depression and plausible mechanisms have been proposed to explain this observed association, which could lead to improved understanding of the association and lead to new interventions to improve cardiac outcomes. This review summarises the evidence linking depression with worse cardiac outcomes, considers specific aspects of depression which may predict worse outcomes and reviews the mechanisms that could potentially explain the direct or indirect association of depression with coronary outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146,538 participants in 54 observational studies. Eur Heart J. 2006;27:2763–74.

    Article  PubMed  Google Scholar 

  2. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66:814–22.

    Article  PubMed  Google Scholar 

  3. de Jonge P, Spijkerman TA, van den Brink RH, et al. Depression after myocardial infarction is a risk factor for declining health related quality of life and increased disability and cardiac complaints at 12 months. Heart. 2006;92:32–9.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Dickens C, Cherrington A, McGowan L. Depression and health-related quality of life in people with coronary heart disease: a systematic review. Eur J Cardiovasc Nurs. 2012;11:265–75.

    Article  PubMed  Google Scholar 

  5. Lauzon C, Beck CA, Huynh T, et al. Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ. 2003;168:547–52.

    PubMed Central  PubMed  Google Scholar 

  6. Shiotani I, Sato H, Kinjo K, et al. Depressive symptoms predict 12 month prognosis in elderly patients with acute myocardial infarction. J Cardiovasc Risk. 2002;9:153–60.

    PubMed  Google Scholar 

  7. Frasure-Smith N, Lesperance F, Gravel G, et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res. 2000;48:471–8.

    Article  CAS  PubMed  Google Scholar 

  8. Kurdyak PA, Gnam WH, Goering P, et al. The relationship between depressive symptoms, health service consumption, and prognosis after acute myocardial infarction: a prospective cohort study. BMC Health Serv Res. 2008;8:200.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Pishgoo B. A novel prediction model for all cause emergency department visits in ischemic heart disease. J Res Med Sci. 2011;16:262–8.

    PubMed Central  PubMed  Google Scholar 

  10. Dickens C, Katon W, Blakemore A, et al. Does depression predict the use of urgent and unscheduled care by people with long term conditions? A systematic review with meta-analysis. J Psychosom Res. 2012;73:334–42.

    Article  PubMed  Google Scholar 

  11. Rutledge T, Vaccarino V, Johnson BD, et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol. 2009;53:176–83.

    Article  PubMed Central  PubMed  Google Scholar 

  12. O'Neil A, Sanderson K, Oldenburg B. Depression as a predictor of work resumption following myocardial infarction (MI): a review of recent research evidence. Health Qual Life Outcomes. 2010;8:95.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802–13.

    Article  PubMed  Google Scholar 

  14. Grace SL, Abbey SE, Kapral MK, et al. Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol. 2005;96:1179–85.

    Article  PubMed  Google Scholar 

  15. de Jonge P, van den Brink RH, Spijkerman TA, et al. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol. 2006;48:2204–8.

    Article  PubMed  Google Scholar 

  16. Dickens C, McGowan L, Percival C, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med. 2008;70:450–5.

    Article  PubMed  Google Scholar 

  17. Parker GB, Hilton TM, Walsh WF et al. Timing Is Everything: The Onset of Depression and Acute Coronary Syndrome Outcome. Biol Psychiatry. 2008.

  18. Lesperance F, Frasure-Smith N, Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med. 1996;58:99–110.

    Article  CAS  PubMed  Google Scholar 

  19. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106–16.

    Article  PubMed  Google Scholar 

  20. Leung YW, Flora DB, Gravely S, et al. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosom Med. 2012;74:786–801. This paper presents a thorough overview of the importance of the timing of depression with regards to the effect of depression on cardaic outcomes.

    Article  PubMed Central  PubMed  Google Scholar 

  21. de Jonge P, Ormel J, van den Brink RH, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry. 2006;163:138–44.

    Article  PubMed  Google Scholar 

  22. Roest AM, Thombs BD, Grace SL, et al. Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality. J Affect Disord. 2011;131:158–63.

    Article  PubMed  Google Scholar 

  23. Linke SE, Rutledge T, Johnson BD, et al. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry. 2009;66:499–507.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Martens EJ, Hoen PW, Mittelhaeuser M, et al. Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med. 2010;40:807–14.

    Article  CAS  PubMed  Google Scholar 

  25. Doyle F, Conroy R, McGee H, et al. Depressive symptoms in persons with acute coronary syndrome: specific symptom scales and prognosis. J Psychosom Res. 2010;68:121–30.

    Article  PubMed  Google Scholar 

  26. Smolderen KG, Spertus JA, Reid KJ, et al. The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009;2:328–37.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Hoen PW, Whooley MA, Martens EJ, et al. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol. 2010;56:838–44.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry. 2003;60:627–36.

    Article  PubMed  Google Scholar 

  29. Hoen PW, Conradi HJ, Denollet J, et al. Interview-based ratings of somatic and cognitive symptoms of depression and their impact on cardiovascular prognosis. Psychother Psychosom. 2010;79:319–20.

    Article  PubMed  Google Scholar 

  30. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19:179–200.

    Article  CAS  PubMed  Google Scholar 

  31. Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004;66:466–74.

    Article  PubMed  Google Scholar 

  32. Banankhah SK, Friedmann E, Thomas S. Effective treatment of depression improves post-myocardial infarction survival. World J Cardiol. 2015;7:215–23.

    PubMed Central  PubMed  Google Scholar 

  33. de Jonge P, Honig A, van Melle JP, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry. 2007;164:1371–8.

    Article  PubMed  Google Scholar 

  34. Glassman AH, Bigger Jr JT, Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry. 2009;66:1022–9.

    Article  PubMed  Google Scholar 

  35. Stapelberg NJ, Neumann DL, Shum DH, et al. A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease. Aust N Z J Psychiatry. 2011;45:351–69.

    Article  PubMed  Google Scholar 

  36. Lehto S, Koukkunen H, Hintikka J, et al. Depression after coronary heart disease events. Scand Cardiovasc J. 2000;34:580–3.

    Article  CAS  PubMed  Google Scholar 

  37. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–88.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Ye S, Muntner P, Shimbo D, et al. Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol. 2013;61:622–30.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Anda RF, Williamson DF, Escobedo LG, et al. Depression and the dynamics of smoking. A national perspective. JAMA. 1990;264:1541–5.

    Article  CAS  PubMed  Google Scholar 

  40. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67:220–9.

    Article  PubMed  Google Scholar 

  41. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–88.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Rutledge T, Kenkre TS, Thompson DV, et al. Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia. Am J Med. 2014;127:840–7.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Vogelzangs N, Kritchevsky SB, Beekman AT, et al. Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 2008;65:1386–93.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Knol MJ, Twisk JW, Beekman AT, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49:837–45.

    Article  CAS  PubMed  Google Scholar 

  45. Bonnet F, Irving K, Terra JL, et al. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005;178:339–44.

    Article  CAS  PubMed  Google Scholar 

  46. Allan JL, Johnston DW, Johnston M, et al. Depression and perceived behavioral control are independent predictors of future activity and fitness after coronary syndrome events. J Psychosom Res. 2007;63:501–8.

    Article  PubMed  Google Scholar 

  47. Brummett BH, Babyak MA, Siegler IC, et al. Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. Am J Cardiol. 2003;92:529–32.

    Article  PubMed  Google Scholar 

  48. Mayou RA, Gill D, Thompson DR, et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med. 2000;62:212–9.

    Article  CAS  PubMed  Google Scholar 

  49. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med. 2000;160:1818–23.

    Article  CAS  PubMed  Google Scholar 

  50. Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88–90.

    Article  PubMed  Google Scholar 

  51. Rieckmann N, Burg MM, Kronish IM, et al. Aspirin adherence, depression and one-year prognosis after acute coronary syndrome. Psychother Psychosom. 2011;80:316–8. Important study demonstrating that impact of depression on cardiac outcomes is partially mediated by compliance with prescribed medication.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Sanderson BK, Bittner V. Women in cardiac rehabilitation: outcomes and identifying risk for dropout. Am Heart J. 2005;150:1052–8.

    Article  PubMed  Google Scholar 

  53. Casey E, Hughes JW, Waechter D, et al. Depression predicts failure to complete phase-II cardiac rehabilitation. J Behav Med. 2008;31:421–31.

    Article  PubMed  Google Scholar 

  54. Wang PS, Bohn RL, Knight E, et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504–11.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Collier DA, Stober G, Li T, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–60.

    CAS  PubMed  Google Scholar 

  56. Furlong RA, Ho L, Walsh C, et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet. 1998;81:58–63.

    Article  CAS  PubMed  Google Scholar 

  57. Nakatani D, Sato H, Sakata Y, et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J. 2005;150:652–8.

    Article  CAS  PubMed  Google Scholar 

  58. Comings DE, MacMurray JP, Gonzalez N, et al. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol Genet Metab. 1999;67:248–53.

    Article  CAS  PubMed  Google Scholar 

  59. McCaffery JM, Duan QL, Frasure-Smith N, et al. Genetic predictors of depressive symptoms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet. 2009;150B:381–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ. 2000;321:199–204.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  61. Ndrepepa G, Braun S, Cassese S, et al. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention. Cardiovasc Revasc Med. 2013;14:264–9.

    Article  PubMed  Google Scholar 

  62. Berton G, Palmieri R, Cordiano R, et al. Acute-phase inflammatory markers during myocardial infarction: association with mortality and modes of death after 7 years of follow-up. J Cardiovasc Med (Hagerstown). 2010;11:111–7.

    Article  Google Scholar 

  63. Madjid M, Awan I, Willerson JT, et al. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004;44:1945–56.

    Article  PubMed  Google Scholar 

  64. Hemingway H, Philipson P, Chen R, et al. Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med. 2010;7:e1000286.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  65. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71:171–86.

    Article  CAS  PubMed  Google Scholar 

  66. Gimeno D, Kivimaki M, Brunner EJ, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39:413–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  67. Stewart JC, Rand KL, Muldoon MF, et al. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun. 2009;23:936–44.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  68. Reichenberg A, Yirmiya R, Schuld A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58:445–52.

    Article  CAS  PubMed  Google Scholar 

  69. Wright CE, Strike PC, Brydon L, et al. Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun. 2005;19:345–50.

    Article  CAS  PubMed  Google Scholar 

  70. Abbott R, Whear R, Nikolaou V et al. Tumour necrosis factor-alpha inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res. 2015.

  71. Beratis S, Katrivanou A, Georgiou S, et al. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment. J Psychosom Res. 2005;58:15–8.

    Article  PubMed  Google Scholar 

  72. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344:961–6.

    Article  CAS  PubMed  Google Scholar 

  73. Miller AH. Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun. 2009;23:149–58.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  74. Miller GE, Freedland KE, Duntley S, et al. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 2005;95:317–21.

    Article  CAS  PubMed  Google Scholar 

  75. Caro MA, Sowden GL, Mastromauro CA, et al. Risk factors for positive depression screens in hospitalized cardiac patients. J Cardiol. 2012;60:72–7.

    Article  PubMed  Google Scholar 

  76. Lesperance F, Frasure-Smith N, Theroux P, et al. The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry. 2004;161:271–7.

    Article  PubMed  Google Scholar 

  77. Nikkheslat N, Zunszain PA, Horowitz MA et al. Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain Behav Immun. 2015.

  78. Schins A, Tulner D, Lousberg R, et al. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res. 2005;39:137–44.

    Article  PubMed  Google Scholar 

  79. Steptoe A, Wikman A, Molloy GJ, et al. Inflammation and symptoms of depression and anxiety in patients with acute coronary heart disease. Brain Behav Immun. 2013;31:183–8.

    Article  PubMed  Google Scholar 

  80. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153:1313–7.

    Article  CAS  PubMed  Google Scholar 

  81. Canan F, Dikici S, Kutlucan A, et al. Association of mean platelet volume with DSM-IV major depression in a large community-based population: the MELEN study. J Psychiatr Res. 2012;46:298–302.

    Article  PubMed  Google Scholar 

  82. Laghrissi-Thode F, Wagner WR, Pollock BG, et al. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997;42:290–5.

    Article  CAS  PubMed  Google Scholar 

  83. Williams MS, Rogers HL, Wang NY, et al. Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome? Psychosomatics. 2014;55:252–60.

    Article  PubMed Central  PubMed  Google Scholar 

  84. Cooper DC, Tomfohr LM, Milic MS, et al. Depressed mood and flow-mediated dilation: a systematic review and meta-analysis. Psychosom Med. 2011;73:360–9.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–57.

    Article  PubMed  Google Scholar 

  86. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363–7.

    Article  CAS  PubMed  Google Scholar 

  87. Kimmig LM, Karalis DG. Do omega-3 polyunsaturated fatty acids prevent cardiovascular disease? A review of the randomized clinical trials. Lipid Insights. 2013;6:13–20.

    PubMed Central  CAS  PubMed  Google Scholar 

  88. Levant B. N-3 (omega-3) polyunsaturated fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence. CNS Neurol Disord Drug Targets. 2013;12:450–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  89. Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry. 2004;55:891–6.

    Article  CAS  PubMed  Google Scholar 

  90. Sontrop J, Campbell MK. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med. 2006;42:4–13.

    Article  CAS  PubMed  Google Scholar 

  91. Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr. 2010;91:757–70.

    Article  CAS  PubMed  Google Scholar 

  92. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr. 2009;28:525–42.

    Article  CAS  PubMed  Google Scholar 

  93. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis. 2007;6:21.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  94. Sublette ME, Ellis SP, Geant AL, et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011;72:1577–84.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  95. Bloch MH, Hannestad J. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis. Mol Psychiatry. 2012;17:1272–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  96. Arborelius L, Owens MJ, Plotsky PM, et al. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol. 1999;160:1–12.

    Article  CAS  PubMed  Google Scholar 

  97. Kaplan JR, Pettersson K, Manuck SB, et al. Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis. Circulation. 1991;84:VI23–32.

    Article  CAS  PubMed  Google Scholar 

  98. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004;55:1–9.

    Article  CAS  PubMed  Google Scholar 

  99. Jouven X, Zureik M, Desnos M, et al. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res. 2001;50:373–8.

    Article  CAS  PubMed  Google Scholar 

  100. Shaper AG, Wannamethee G, Macfarlane PW, et al. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br Heart J. 1993;70:49–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  101. Agelink MW, Boz C, Ullrich H, et al. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res. 2002;113:139–49.

    Article  PubMed  Google Scholar 

  102. Carney RM, Saunders RD, Freedland KE, et al. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 1995;76:562–4.

    Article  CAS  PubMed  Google Scholar 

  103. Carney RM, Blumenthal JA, Freedland KE, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med. 2005;165:1486–91.

    Article  PubMed  Google Scholar 

  104. Kamphuis MH, Geerlings MI, Dekker JM, et al. Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study. Eur J Cardiovasc Prev Rehabil. 2007;14:796–802.

    Article  PubMed  Google Scholar 

  105. Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biol Psychol. 2007;74:200–11.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Chris Dickens declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article is based on published papers and does not contain any examination with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. University of Exeter Medical School, College House, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU, UK

    Chris Dickens

Authors
  1. Chris Dickens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chris Dickens.

Additional information

This article is part of the Topical Collection on Psychological Aspects of Cardiovascular Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dickens, C. Depression in People with Coronary Heart Disease: Prognostic Significance and Mechanisms. Curr Cardiol Rep 17, 83 (2015). https://doi.org/10.1007/s11886-015-0640-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-015-0640-6

Keywords

Search

Navigation